ベンチャー探訪　Typewriter Therapeutics社、レトロトランスポゾンを遺伝子治療に応用へ | AN Venture Partners

ベンチャー探訪　Typewriter Therapeutics社、レトロトランスポゾンを遺伝子治療に応用へ

MediaPortfolio Companies

ベンチャー探訪　Typewriter Therapeutics社、レトロトランスポゾンを遺伝子治療に応用へ

July 5, 2024

Typewriter Therapeutics Emerges from Stealth with $56 Million Series A Financing to pursue in vivo CAR T medicines

Press Release

Portfolio Companies

Typewriter Therapeutics Emerges from Stealth with $56 Million Series A Financing to pursue in vivo CAR T medicines

Cambridge, Mass., September 2, 2026

Crystalys Therapeutics Closes $130 Million Series B Funding to Advance Global Phase 3 Development and Commercialization of Dotinurad for Gout

Press Release

Portfolio Companies

Crystalys Therapeutics Closes $130 Million Series B Funding to Advance Global Phase 3 Development and Commercialization of Dotinurad for Gout

San Diego, July 23, 2026

Privacy Policy

This website uses Google Analytics cookies for access analysis only. The collected data is used solely for improving the website and is handled appropriately. By clicking "AGREE", you consent to the use of cookies.

Privacy Policy

This website uses Google Analytics cookies for access analysis only. The collected data is used solely for improving the website and is handled appropriately. By clicking "AGREE", you consent to the use of cookies.